Publications by authors named "Georges Fillet"

Claim this Profile
L
Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.
Aurélie Jaspers, Frédéric Baron, Johan Maertens, Bernard De Prijck, Rik Schots, Georges Fillet

Am J Hematol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
Roelof Willemze, Stefan Suciu, Giovanna Meloni, Boris Labar, Jean-Pierre Marie, Georges Fillet

J Clin Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial.
Yves Beguin, Johan Maertens, Bernard De Prijck, Rik Schots, Laurence Seidel, Georges Fillet

Am J Hematol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA).
Aurélie Jaspers, Jo Caers, Gerald Le Gac, Claude Ferec, Yves Beguin, Georges Fillet

Br J Haematol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHIC cells: a novel ALK+ cell line derived from a relapsed anaplastic large cell lymphoma.
Caroline Thielen, Bettina Bisig, Stéphanie Gofflot, Christian Herens, Georges Fillet

Br J Haematol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group.
Boris Labar, Stefan Suciu, Roel Willemze, Petra Muus, Jean-Pierre Marie, Georges Fillet

Haematologica· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Frédéric Baron, Chantal Lechanteur, Evelyne Willems, France Bruck, Etienne Baudoux, Georges Fillet

Biol Blood Marrow Transplant· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosis.
Kaoutar Hafraoui, Michel Moutschen, Julie Smet, Françoise Mascart, Nicole Schaaf-Lafontaine, Georges Fillet

Eur J Intern Med· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971.
Bruno Coudert, Christian Focan, Dominique Genet, Sylvie Giacchetti, Frédérique Cvickovic, Georges Fillet

Chronobiol Int· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
Christophe Bonnet, Yves Beguin, Marie-France Fassotte, Laurence Seidel, Françoise Luyckx, Georges Fillet

Eur J Haematol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte.
Christophe Bonnet, Georges Fillet, Nicolas Mounier, Gérard Ganem, Thierry Jo Molina

J Clin Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
Gaëtan Vanstraelen, Frédéric Baron, Evelyne Willems, Christophe Bonnet, Kaoutar Hafraoui, Georges Fillet

Exp Hematol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation.
Gaëtan Vanstraelen, Pascale Frère, Marie-Christine Ngirabacu, Evelyne Willems, Georges Fillet

Exp Hematol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation.
Pascale Frère, Maguy Pereira, Georges Fillet, Yves Beguin

Eur J Haematol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron emission tomography imaging for lymphoma.
Guy Jerusalem, Roland Hustinx, Yves Beguin, Georges Fillet

Curr Opin Oncol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation.
Gaëtan Vanstraelen, Frédéric Baron, Pascale Frère, Kaoutar Hafraoui, Georges Fillet

Haematologica· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of therapy for lymphoma.
Guy Jerusalem, Roland Hustinx, Yves Beguin, Georges Fillet

Semin Nucl Med· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer.
Frédéric Baron, Sandra Copizza, Etienne Baudoux, Guy Jerusalem, Georges Fillet

Haematologica· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients
Boris Labar, Stefan Suciu, Robert Zittoun, Petra Muus, Jean Pierre Marie, Georges Fillet

Haematologica· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.
Herve Tilly, Eric Lepage, Bertrand Coiffier, Michel Blanc, Raoul Herbrecht, Georges Fillet

Blood· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
Frédéric Baron, Nicole Schaaf-Lafontaine, Stéphanie Humblet-Baron, Nathalie Meuris, Emilie Castermans, Georges Fillet

Transplantation· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
Frédéric Baron, Pascale Frère, Georges Fillet, Yves Beguin

Clin Cancer Res· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion.
Frédéric Baron, Pascale Frère, Georges Fillet, Yves Beguin

Br J Haematol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update.
Frédéric Baron, Pascale Frère, Etienne Baudoux, Nicole Schaaf-Lafontaine, Georges Fillet

Haematologica· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma.
Frédéric Baron, Pascale Frère, Etienne Baudoux, Brieuc Sautois, Georges Fillet

Haematologica· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis